Securities code: 603676 securities abbreviation: Tibet Weixinkang Medicine Co.Ltd(603676) Announcement No.: 2022-001
Tibet Weixinkang Medicine Co.Ltd(603676)
Suggestive announcement on the reduction of more than 1% by shareholders holding more than 5%
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Important content tips:
This equity change belongs to the reduction of shares held by shareholders holding more than 5%, which will not touch the tender offer and will not lead to changes in the controlling shareholder and actual controller of the company.
After this equity change, the proportion of shares of listed companies held by Tianjin Jing Tibet Weixinkang Medicine Co.Ltd(603676) management consulting partnership (limited partnership), the information disclosure obligor, Zhang Yong and Tibet Tibet Weixinkang Medicine Co.Ltd(603676) Investment Management Co., Ltd. will be reduced from 70.19% to 69.18%.
Tibet Weixinkang Medicine Co.Ltd(603676) (hereinafter referred to as “the company”) received the notification letter on equity change exceeding 1% from Tianjin Jing Tibet Weixinkang Medicine Co.Ltd(603676) management consulting partnership (limited partnership), an information disclosure obligor, on December 30, 2021, from December 24, 2021 to December 30, 2021, The information disclosure obligors reduced 4377400 shares of the company through centralized bidding and block trading, accounting for 1.00% of the total share capital of the company. The changes in equity are hereby announced as follows:
1、 Basic information of this equity change
Name: Tianjin Jing Tibet Weixinkang Medicine Co.Ltd(603676) management consulting partnership (limited partnership)
Information disclosure obligation domicile: room 217, building 14, No. 2, Hongwang Road, Beijing Tianjin e-commerce Industrial Park, Wuqing District, Tianjin
Time: December 24, 2021 – December 30, 2021
Change method change date number of shares (shares) decrease proportion type (%)
Centralized bidding December 24, 2021 – details of equity changes of RMB 23634000.54 ordinary shares on December 30, 2021
Block trading December 24, 2021 – RMB 20140000.46 ordinary shares on December 30, 2021
Total — 43774001.00
Name: Zhang Yong
Address of information disclosure obligation: courtyard 9, FengHao East Road, Haidian District, Beijing
Changes in basic information and interests of the owner
Time: December 24, 2021 – December 30, 2021
Change method change date number of shares (shares) decrease proportion type (%)
Details of changes in equity—–
Total—-
Name: Tibet Tibet Weixinkang Medicine Co.Ltd(603676) Investment Management Co., Ltd
Address of information disclosure obligation: 402-2, unit 2, building 1, zone B, sunshine new town, 158 Jinzhu West Road, Lhasa
Changes in basic information and interests of the owner
Time: December 24, 2021 – December 30, 2021
Change method change date number of shares (shares) decrease proportion type (%)
Details of changes in equity—–
Total—-
Note:
1. The last equity change date was December 21, 2021. After the equity change, the information disclosure obligors and their persons acting in concert held 306038700 shares of the company, accounting for 70.19% of the total share capital of the company at that time.
2. All the shares involved in this equity change enjoy voting rights, and there are no rights restrictions or restricted transfers such as voting rights entrustment or restriction.
3. This change does not violate the securities law, the measures for the administration of the acquisition of listed companies and other laws and regulations, the business rules of Shanghai Stock Exchange and other relevant provisions and relevant commitments.
2、 Before and after this equity change, information disclosure obligors and persons acting in concert held shares of the company
Shares held before this change shares held after this change
Shareholder name share nature in total share capital in total share capital number of shares (shares) cases (%) number of shares (shares) cases (%)
Tianjin jingweixin holds 4738734010.87430099409.86 shares in total
Health management consulting
Including: unlimited 4738734010.87430099409.86
(shares with limited conditions of sale)
(2) limited sale conditions – shares
Total 5340240012.255340240012.25 shares held
Zhang Yong, including: unlimited 5340240012.255340240012.25 shares with sales conditions
Limited sales conditions – shares
Total 20524896047.0720524896047.07 Tibet Tibet Weixinkang Medicine Co.Ltd(603676) shares held
Investment management includes: shares with unlimited sales conditions 20524896047.0720524896047.07
Limited sales conditions – shares
Total 30603870070.1930166130069.18
Note: all the shares of the company held after this equity change enjoy voting rights, and there are no rights restrictions or restricted transfers such as voting rights entrustment or restriction.
3、 Follow up matters involved
1. The part of centralized bidding and block trading in this equity change is that the information disclosure obligor performs the disclosed reduction plan (Announcement No.: 2021-057). The information disclosure obligor intends to reduce the company’s shares by centralized bidding within 6 months after 15 trading days from the date of disclosure of the reduction plan announcement, or reduce the company’s shares by block trading within 6 months after 3 trading days from the date of disclosure of the reduction plan announcement, with a total reduction of no more than 13033770 shares. As of December 30, 2021, the information disclosure obligors had reduced 8302300 shares of the company, and the remaining 4731470 shares had not been completed.
2. This equity change will not lead to changes in the controlling shareholder and actual controller of the company.
3. This equity change belongs to the reduction of shares held by shareholders holding more than 5%, which does not involve the tender offer and the source of funds.
It is hereby announced.
Tibet Weixinkang Medicine Co.Ltd(603676) board of directors January 4, 2022
